Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Even if FDA approves Xarelto, Pradaxa could still gain
Even if FDA approves Xarelto, Pradaxa could still gain
Even if FDA approves Xarelto, Pradaxa could still gain
Submitted by
admin
on September 12, 2011 - 10:39am
Source:
Fierce Pharma
News Tags:
FDA
Xarelo
Pradaxa
bloodthinners
Bayer
JNJ
Boehringer Ingelheim
Headline:
Even if FDA approves Xarelto, Pradaxa could still gain
Do Not Allow Advertisers to Use My Personal information
